Lexaria Bioscience Corp. (LEXX): Total Assets
$4.18M
As of 2025-08-31
$4.78M
As of 2026-05-31
-18.9%
3-year compound annual growth
+8.1%
5-year compound annual growth
+19.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-08-31 | $4.18M | -52.9% | 2025-11-28, Balance as of period end |
| 2024-08-31 | $8.87M | +187.5% | 2025-11-28, Balance as of period end |
| 2023-08-31 | $3.08M | -60.6% | 2024-11-26, Balance as of period end |
| 2022-08-31 | $7.83M | -41.0% | 2023-11-20, Balance as of period end |
| 2021-08-31 | $13.27M | +369.1% | 2022-11-28, Balance as of period end |
| 2020-08-31 | $2.83M | +5.7% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $2.68M | +10.0% | 2020-10-15, Balance as of period end |
| 2018-08-31 | $2.43M | -15.0% | 2019-11-14, Balance as of period end |
| 2017-08-31 | $2.86M | +404.8% | 2018-11-14, Balance as of period end |
| 2016-08-31 | $566.6K | -20.4% | 2017-11-27, Balance as of period end |
| 2015-08-31 | $711.7K | -73.0% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $2.64M | n/a | 2015-11-27, Balance as of period end |
| 2013-10-31 | $3.57M | -14.8% | 2014-01-24, Balance as of period end |
| 2012-10-31 | $4.19M | -3.4% | 2014-01-24, Balance as of period end |
| 2011-10-31 | $4.34M | +32.4% | 2013-01-29, Balance as of period end |
| 2010-10-31 | $3.28M | n/a | 2012-01-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $44.92M | +17.2% |
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $51.76M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
Compare LEXX, PMHS, BTAIQ, HYPD side by side · Screen every company in Pharmaceutical Preparations ↗